quinoxalines has been researched along with noc 18 in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (25.00) | 18.2507 |
2000's | 2 (50.00) | 29.6817 |
2010's | 1 (25.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Galle, J; Hatzelmann, A; Hübner, U; Schmidt, HH; Wagner, B; Wanner, C; Zabel, U | 1 |
Becherini, L; MacIntyre, I; Mancini, L; Martineti, V; Moradi-Bidhendi, N | 1 |
Campbell, C; Komai-Koma, M; Liew, FY; Niedbala, W; Thomson, D; Wei, XQ | 1 |
Altun, A; Bagcivan, I; Durmus, N; Gursoy, S; Ozdemir, E | 1 |
4 other study(ies) available for quinoxalines and noc 18
Article | Year |
---|---|
Effects of the soluble guanylyl cyclase activator, YC-1, on vascular tone, cyclic GMP levels and phosphodiesterase activity.
Topics: Animals; Aorta, Thoracic; Cyclic GMP; Enzyme Activation; Enzyme Inhibitors; Guanylate Cyclase; In Vitro Techniques; Indazoles; Isoenzymes; Kinetics; Muscle Contraction; Muscle Relaxation; Muscle Tonus; Muscle, Smooth, Vascular; Nitric Oxide Donors; Nitroprusside; Nitroso Compounds; Oxadiazoles; Phosphoric Diester Hydrolases; Quinoxalines; Rabbits; Vasodilator Agents | 1999 |
The biphasic effects of nitric oxide in primary rat osteoblasts are cGMP dependent.
Topics: Alkaline Phosphatase; Animals; Apoptosis; Cell Division; Cells, Cultured; Cyclic GMP; Dose-Response Relationship, Drug; Enzyme Inhibitors; Nitric Oxide; Nitric Oxide Donors; Nitroprusside; Nitroso Compounds; Osteoblasts; Oxadiazoles; Quinoxalines; Rats; Rats, Wistar | 2000 |
Nitric oxide preferentially induces type 1 T cell differentiation by selectively up-regulating IL-12 receptor beta 2 expression via cGMP.
Topics: Animals; CD8-Positive T-Lymphocytes; Cells, Cultured; Cyclic GMP; Enzyme Activation; Enzyme Inhibitors; Female; Gene Expression Regulation; Guanylate Cyclase; Humans; Male; Mice; Mice, Inbred BALB C; Models, Immunological; Nitric Oxide; Nitric Oxide Donors; Nitric Oxide Synthase; Nitroso Compounds; Oxadiazoles; Polymerase Chain Reaction; Quinoxalines; Receptors, Interleukin; Receptors, Interleukin-12; Receptors, Interleukin-4; Signal Transduction; Th1 Cells; Th2 Cells | 2002 |
Soluble guanylyl cyclase activators increase the expression of tolerance to morphine analgesic effect.
Topics: Analgesics, Opioid; Animals; Drug Tolerance; Enzyme Activators; Enzyme Inhibitors; Guanylate Cyclase; Male; Molsidomine; Morphine; Nitric Oxide Donors; Nitroso Compounds; Oxadiazoles; Photosensitizing Agents; Protoporphyrins; Quinoxalines; Rats; Rats, Wistar; Receptors, Cytoplasmic and Nuclear; Restriction Mapping; S-Nitroso-N-Acetylpenicillamine; Soluble Guanylyl Cyclase | 2014 |